ASTRAZENECA PLC (AZN)
Clinical trial NCT06512883 updates: 1. completion date: 2028-04-03 → 2029-05-14 2. enrollment: not set → 14 participants
Clinical trial NCT06512883 updates: 1. completion date: 2028-04-03 → 2029-05-14 2. enrollment: not set → 14 participants
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical